Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Research Project

RESEARCH

FUNDED PROJECTS

Ongoing

S.No.

 

Titleofthe project

NameofPrincipal

Investigator

Fundedby(Name

orfundingagency)

Duration

years

Startyear

Endyear

Totalfunds

Sanctioned(Rs)

1.

Regional Virus Research and Diagnostic Laboratory (RL-VRDL)

Dr. Lalit Dar

Department of Health Research (DHR)

10 years (extendable)

2019

Continuous

~ 5 crore

2.

External Quality Assurance Scheme (EQAS) of National HIV/AIDS Reference Laboratory, AIIMS, Delhi

Dr. Bimal Kr. Das

NACO

Continuous

2005

Continuous

Approx. 14 lacs/annum

3.

HIV integrated counseling and testing (ICTC)

Dr. Bimal Kr. Das

NACO

Continuous

2005

Continuous

Kits are provided by NACO and the rest is taken care of under EQAS budget

4.

CD4 testing program

Dr. Bimal Kr. Das

NACO

Continuous

2005

Continuous

Testing kits provided by NACO, Rs. 50,000/- for Consumables

5

Evaluation of NF- κB based reactivation of latency in HIV infected individuals who are on antiretroviral therapy for more than 15 years: A Quest for Cure.

Dr. Shesh Prakash Maurya (under mentorship of Bimal Kumar Das).

Funded by DHR (HRD scheme)

3 years

2022

2025

Rs. 50,92,497/-

6

Evaluation of role of B-1 cells in modulating the response of T cells in HIV infected patients pre and post antiretroviral therapy: cohort study.

Dr. Bimal Kumar Das

Funded by ICMR

3 years

2022

2025

Rs. 50,40,572/-

7

Nodal coordinating center for surveillance network of antimicrobial resistance in salmonella enterica serotype Typhi and Paratyphi

 

Dr. Bimal Kumar Das

Funded by ICMR

2 YEAR

2018

2024

2,39, 22,040

8

Detection of salmonella serovars and their associated resistance marker directly from blood specimen using paper based DNA biosensor

Dr. Bimal Kumar Das

Funded by ICMR

2 YEAR

2024

2026

1,35,68,808

9

Proteomics study of Giardia intestinalis isolates to associate with different clinical spectrum and extrapolate its invasive potential

Dr. B.R Mirdha

ICMR

3 years

Sept, 2023

August, 2026

48 lakhs

10

Characterization of human antibody responses to Plasmodium vivax in India”. (Through Inspire faculty programme)

Dr. B.R Mirdha

Department of Science and Technology

5 years

August , 2023

2028

More than 5 Cr.

11

ICMRs: Advanced Mycology Diagnostic and Research Centre (AMDRC)

Prof Immaculata Xess

ICMR

5 years

2022

2027

250 lakhs

12

Multi-centric study on prevalence of Mycoplasma genitalium and its resistance markers in the high–risk group (MSM and FSW) attending sexually transmitted disease cclinics in North India.

Benu Dhawan

ICMR

3 years

December2021

December 2024

28.65 Lakhs

13

Towards point of care test development for Bacterial Vaginosis, a polymicrobial infection.

Dr. Seema Sood

ICMR

3 years

2020

2023

51 Lakhs

14

Exploring SELEX technology for potential POCT development for Genital Chlamydia trachomatis.

Dr. Seema Sood

ICMR

3 years

2022

2025

50 Lakhs

15

Point-of-care test development for Bacterial Vaginosis (BV): Bench to bedside (Clinical validation of proof-of-concept).

Dr. Seema Sood

ICMR

3 years

2024

2027

75 Lakhs

16

Mapping hotspots of MDR-TB in Assam, Sikkim and Tripura using Genomics approaches

Dr. Urvashi B. Singh

DBT-NER

3 years

2018

2024

~ 4 Cr

17

Epidemiological impact and intersection of the COVID-19 and Tuberculosis Pandemics in Brazil, Russia, India and South Africa

Dr. Urvashi B. Singh

DST

2 years

2021

2023

1.72 Cr

18

Validation of Indigenously Developed Diagnostic kit based on Detection of Proteomic markers from Urine for Diagnosis of Pulmonary and Extra-pulmonary Tuberculosis

Dr. Urvashi B. Singh

ICMR

3 years

2022

2025

1.4 cr

19

Operational Feasibility and performance of indigenous phenotypic kit for detection of multidrug resistant tuberculosis and extensively drug resistant tuberculosis in field setting under the National Tuberculosis Elimination program

Dr. Urvashi B. Singh

ICMR

3 years

2022

2025

14 lakhs

20

Development of Surface Plasmon Resonance Array Biosensor for Rapid Molecular Drug Resistance Detection for MDR and XDR TB

Dr. Urvashi B. Singh

ICMR

2 years

2023

2025

40 Lakhs

21

Development of Surface Enhanced Raman Scattering (SERS) Based Biosensor for Rapid Detection of oligonucleotides in MDR and XDR-TB.

Dr. Urvashi B. Singh

AIIMS-IITD

2 years

2022

2024

10 Lakhs

22

A Preclinical Study to evaluate synergistic action of Rifampicin with Faropenem and Cefdinir on persister Mycobacterium tuberculosis bacilli in mouse model.

Dr. Urvashi B. Singh

AIIMS-THSTI

2 years

2023

2025

10 Lakhs

23

To determine the prevalence of common virulence determinants associated with Uropathogenic Escherichia coli from community-setting at different geographical regions of India using phenotypic and genotypic methods

Dr. Sarita Mohapatra

ICMR

3 year

2022

2025

Rs553400.00

24

Platform for discovery of novel therapeutic monoclonal antibodies against MDR and XDR Klebsiella pneumoniae

Sarita

Mohapatra (Co-PI)/year

DBT-BIRAC

3 years

2023

2026

Rs. 4,88,840.00

25

Micro-nano structured urinary catheter to minimize catheter-associated urinary tract infection

Sarita

Mohapatra (Co-PI)

MoE-STARS

3 years

2023

2026

Rs 32.6 lacs

26

National Program for the Surveillance of Viral Hepatitis

 

Dr. Aashish Choudhary

Ministry of Health & Family Welfare (MoHFW)

5 years (extendable)

2020

Continuous

~ 1.3 crore

27

NACO Regional Reference Laboratory for HIV viral load (VL)

Dr. Aashish Choudhary

National AIDS Control Organization (NACO)

No fixed duration

2019

Continuous

~ 51 lakhs

 

28

NACO Regional Reference Laboratory for HIV early infant diagnosis (EID)

Dr. Aashish Choudhary

National AIDS Control Organization (NACO)

No fixed duration

2012

Continuous

~ 93 lakhs

29

Whole genome sequencing of the SARS-CoV-2 novel coronavirus strains at a tertiary care center in Delhi.

Dr. Aashish Choudhary

AIIMS Delhi (Intramural grant)

2 years

2020

2023

~ 11 lakhs

30

Molecular Epidemiology and In-Vitro Antifungal Susceptibility of Cryptic Aspergillus species from Clinical and Environment samples

Dr. Gagandeep Singh

ICMR

3 years

2022

2025

35 lakhs

31

Genomic profiling of invasive and hospital acquired Escherichia coli pathotypes from different clinical samples to identify the virulence and antimicrobial resistance markers

Dr. Hitender Gautam

Science & Engineering Research Board SERB (Under DST)

2 years 6 months

Mar 2022

Sept 2024

45,45,816/-

32

Site-specific biomarkers to differentiate infection from either colonization or aseptic inflammation in ICU

Dr. Hitender Gautam

ICMR

3 years

Jan 2023

Dec 2025

73,39,362/-

33

Molecular Characterization of diarrheagenic Escherichia coli among children with acute diarrhea: Association of virulence and adherence genes.

AIIMS Site PI: Dr. Hitender Gautam

Department of Health Research (DHR)

3 years

Jan 2024

Dec 2026

20,42,367/-

34

PlatPlatform for enhanced pathogen detection for meningitis and sepsis: Rapid, portable, and field-deployable diagnostics. IIRPIG-2023-0001405

AIIMS Site PI: Dr. Hitender Gautam

ICMR

4 years

Mar 2024

Feb 2027

93,46,030/-

35

Detection of viable but non-culturable (VBNC) Gram-negative bacteria in sepsis and meningitis: Clinical significance in AMR stewardship

AIIMS Site PI: Dr. Hitender Gautam

AIIMS-THSTI Collaborative Project

2 years

Dec 2023

Dec 2025

10 Lakhs

36

Antimicrobial susceptibility patterns of pathogens isolated in bloodstream infections vis a vis antibiotic prescribing practices and genotypic clonality of Acinetobacter baumannii in various patient care units/areas

Dr. Hitender Gautam

Inter-Disciplinary AIIMS IMRG.

1 year

Jan 2024

Jan 2025

4,90,350/-

37

Clinical and epidemiological study of Lyme disease: a multi-centric taskforce study in India

Dr. Nishant Verma

ICMR

3

2020

2023

3,86,71,240/-

38

Proteomics study of Giardia intestinalis isolates to associate with different clinical spectrum and extrapolate its invasive potential

Dr. Nishant Verma

ICMR

3

2023

2026

48,69,222

39

Expanded viral etiological investigation of genital ulcer disease with phenotyping and genotyping for antiviral drug resistance in herpes simplex viruses

Dr. Megha Brijwal

ICMR

3 years

2023

2026

~ 59 lakhs

40

Strengthening Capacity for Genomic Sequencing of Outbreak Prone Respiratory Pathogens like Influenza and Other Respiratory Viruses

Dr. Megha Brijwal

CDC & APHL, USA

5 months

2023

2023

~ 40 lakhs

41

Quantification of JC polyomavirus in CSF in patients with suspected progressive multifocal leukoencephalopathy (PML) by digital PCR

Dr. Megha Brijwal

AIIMS Delhi (Intramural grant)

1 year

2023

2024

~ 5 lakhs

42

Non-tubercular mycobacteria responsible for pulmonary disease and infections in procedures involving prosthetic devices, laparoscopy or following other interventions.

Dr. Kiran Bala

AIIMS, Intramural

1 year

2023

2024

4.95 Lakhs

43

Detection of Mycoplasma pneumoniae infections in acute exacerbation of Chronic Obstructive Pulmonary Disease

Dr. Tanu Sagar

AIIMS Intramural

2 years

2024

2026

9.8 Lakhs

 

Completed

 

S.No.

Titleofthe

project

NameofPrincipal

Investigator

Fundedby (Name

offundingagency)

Duration

(years)

Startyear

Endyear

Totalfunds

sanctioned(Rs)

1

Comparison of diagnostic accuracy of Real time PCR versus Nugent’s scoring in Indian women with and without Bacterial Vaginosis (BV). Award of SRFship

Dr. Seema Sood

ICMR

3 years

2019

2022

16.6 Lakhs

2

Early Bactericidal Activity (EBA) of Rifampicin and Feropenem in Tuberculosis (Rifampicin Susceptible)-

Dr. Urvashi B. Singh

ICMR

2 Years

2019

2022

70 Lakhs

3

Early Bactericidal Activity (EBA) and Pk/Pd Study of Rifampicin Feropenem Cefdinir with Clavulanate vs Standard of Care in Newly Diagnosed Smear Positive Rifampicin Susceptible TB

Dr. Urvashi B. Singh

ICMR

2 Years

2019

2023

70 Lakhs

4

Rapid Molecular Drug Resistance Detections for MDR and XDR-TB and Molecular Typing of Mycobacterium Tuberculosis From Ziehl-Neelsen’s Stained Microscopic Slides From Delhi State.

Dr. Urvashi B. Singh

ICMR

3 Years

2018

2022

~ 60 Lakhs

5

Diagnosis of Pulmonary And Extra-Pulmonary Tuberculosis Patients Using

Differentially Expressed Proteins As Potential Biomarkers: An Approach Towards

Development Of Point Of Care Test.

Dr. Urvashi B. Singh

ICMR

3 Years

2018

2022

60 lakhs

6

Crohn’s Disease in India: A multicenter study from a country where intestinal

tuberculosis as well as Johne’s disease is endemic.

Dr. Urvashi B. Singh

ICMR/DHR

5 Years

2016

2022

35 lacs

7

In vitro susceptibility of Cefiderocol against carbapenem-resistant gram-negative bacilli from patients with blood stream infection/sepsis, urinary tract infection or pneumonia

Dr. Sarita

Mohapatra

Funded (Intramural)

2yr

2021

2023

9.7lacs

8

Implementation of An Institutional Antifungal Stewardship Program (AFSP) On The Appropriate Use Of Antifungal Therapy And Outcomes In Patients With Invasive Fungal Infections.

Dr. Gagandeep Singh

ICMR

3 years

2020

2023

48 lakhs

9

Study of hyaline non-sporulating moulds isolated from clinical samples of tertiary care respiratory hospital in Delhi

Dr. Gagandeep Singh

ICMR

3 years

2021

2024

27 lakhs

10

Magnitude of asymptomatic malaria infections in pregnant women in a community hospital

Dr. Nishant Verma

AIIMS, New Delhi

1

2018

 

2019 (work continued in previous year too)

4,98,000/-

11

A prospective study of viral infections in hematopoietic stem cell transplant recipients at a tertiary care hospital in India

Dr. Megha Brijwal

ICMR

3 years

2019

2023

45 lakhs

12

Point of care Urinary Lipoarabinomannan antigen (LAM) detection as a diagnostic tool for

Extra-pulmonary tuberculosis.

Dr. Kiran Bala

AIIMS, Intramural

2 year

2021

2023

4.94 Lakhs

13

Changing epidemiology of tuberculosis among SARS CoV-2 pandemics.

Dr. Kiran Bala

AIIMS, Intramural

2 year

2021

2023

7.14 Lakhs

 

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page
BCMath lib not installed. RSA encryption unavailable